Shares of Danone (OTCMKTS:DANOY - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the six brokerages that are covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, two have issued a buy rating and one has assigned
Like-for-like sales rose 4.7% rise but a series of infant formula recalls have cast a pall over the food company's latest results.
Traces of a toxin that can cause nausea and vomiting were found in two types of infant formula recalled by France's Danone earlier this month, Swiss authorities said on Wednesday.
Nestle and Danone face investor pressure to spell out the financial impact of their biggest infant formula recalls in recent history, and show they have learnt lessons from crises that have hit their shares and left dozens of babies ill.
The Paris public prosecutor announced on Friday investigations into five companies making baby formula. The probe follows worldwide recalls that have left both parents and investors on edge after the toxin cereulide was found in infant nutrition products.
Danone is recalling more than 120 batches of infant formula in Austria due to possible contamination with toxin cereulide, Bloomberg News reported on Thursday.
Danone has recalled at least three batches of its Aptamil baby formula in Germany, a letter to a wholesaler showed on Thursday, as the French food producer scrambles to contain a scare over a toxin contamination that started with Nestle products.
Danone (DANOY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Here is how Danone (DANOY) and Kirin Holdings Co. (KNBWY) have performed compared to their sector so far this year.
The company posted sales growth of 4.8% on a like-for-like basis, fueled by accelerating growth in China despite a continued slowdown in North America.
Here is how Danone (DANOY) and Ollie's Bargain Outlet (OLLI) have performed compared to their sector so far this year.
Danone is introducing an Oikos brand drink targeting U.S. consumers using weight loss medications such as Wegovy, pledging the dairy-based beverage helps address the common concern of retaining muscle.